or
forgot password

High Dose Chemotherapy With Autologous Bone Marrow Transplantation in the Treatment of Metastatic Breast Cancer


N/A
18 Years
70 Years
Not Enrolling
Female
Breast Neoplasms

Thank you

Trial Information

High Dose Chemotherapy With Autologous Bone Marrow Transplantation in the Treatment of Metastatic Breast Cancer


There are 2 phases to this study: 1) Induction- which consists of the administration of
chemotherapeutic drugs- at the end of this phase if the cancer has responded, bone marrow
will be collected and frozen untol ready for re-infusion; 2) 2nd phase- involves high-doses
of chemotherapy followed by infusion of bone marrow cells


Inclusion Criteria:



- Histologically confirmed diagnosis of breast cancer

- Age 18-70

- Breast cancer at first clinical evidence of metastatic disease

- Must have objectively measurable or evaluable disease or be in complete remission

Exclusion Criteria:

- Previous diagnosis of another invasive carcinaom within 10 years (except skin cancer)

- CNS involvement

Type of Study:

Interventional

Study Design:

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Once 10 patients enrolled in the study ar followed for at least 6 months, a preliminary analysis of the data will occur.

Outcome Time Frame:

Undetermined

Safety Issue:

No

Principal Investigator

George Selby, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Oklahoma

Authority:

United States: Institutional Review Board

Study ID:

OU 9206

NCT ID:

NCT00584428

Start Date:

June 1992

Completion Date:

March 2002

Related Keywords:

  • Breast Neoplasms
  • Breast Cancer
  • Cancer Treatment
  • Breast Cancer Treatment
  • Breast Neoplasms
  • Neoplasms

Name

Location
University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma  73104